NCT03425799View on ClinicalTrials.gov

Efficacy and Safety of Tranexamic Acid in Spinal Fusion Surgery

PHASE3TerminatedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

October 17, 2018

Primary Completion Date

October 23, 2019

Study Completion Date

January 21, 2020

Conditions
Spinal Fusion
Interventions
DRUG

Sodium Chloride 0.9% Inj

Inactive ingredient mixture for injection without drug, intravenous infusion bags containing normal saline, manufactured and provided by Exela Pharma Sciences, LLC from a single batch / lot.

DRUG

Tranexamic Acid

Tranexamic Acid Intravenous Infusion Bags (10 mg/mL), manufactured and provided by Exela Pharma Sciences, LLC from a single batch / lot.

Trial Locations (4)

10016

Spine Care Orthopedics - NYU Lagone Medical Center, New York

60612

Rush University Medical Center - Division of Spine Surgery, Chicago

90048

Cedars-Sinai Medical Center, Los Angeles

90806

Memorial Orthopaedic Surgery Group, Long Beach

Sponsors
All Listed Sponsors
lead

Exela Pharma Sciences, LLC.

INDUSTRY